Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Neuroprostanes [FA0401]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA04010453 13,20-diepi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1S,2R)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010454 ent-20-A4-NeuroP (4Z,7Z,10Z)-12-((1S,2S)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010455 20-A4-NeuroP (4Z,7Z,10Z)-12-((1R,2R)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010456 ent-13,20-diepi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1R,2S)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010457 13-epi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1S,2R)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010458 ent-20-epi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1S,2S)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010459 4-epi-4-J4-NeuroP (R,E)-4-hydroxy-6-((1S,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010460 ent-7-epi-4-J4-NeuroP (R,E)-4-hydroxy-6-((1S,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010461 4,7-diepi-4-J4-NeuroP (R,E)-4-hydroxy-6-((1R,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010462 ent-4-J4-NeuroP (R,E)-4-hydroxy-6-((1R,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010463 4-J4-NeuroP (S,E)-4-hydroxy-6-((1S,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010464 ent-4,7-diepi-4-J4-NeuroP (S,E)-4-hydroxy-6-((1S,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010465 7-epi-4-J4-NeuroP (S,E)-4-hydroxy-6-((1R,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010466 ent-4-epi-4-J4-NeuroP (S,E)-4-hydroxy-6-((1R,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010467 7-epi-7-J4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1S,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010468 ent-10-epi-7-J4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1S,5R)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010469 7,10-diepi-7-J4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1R,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010470 ent-7-J4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1R,5R)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010471 7-J4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010472 ent-7,10-diepi-7-J4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,5R)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010473 10-epi-7-J4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1R,5S)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010474 ent-7-epi-7-J4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1R,5R)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010475 10-epi-10-J4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010476 ent-13-epi-10-J4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010477 10,13-diepi-10-J4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010478 ent-10-J4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010479 10-J4-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010480 ent-10,13-diepi-10-J4-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010481 13-epi-10-J4-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010482 ent-10-epi-10-J4-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010483 11-epi-11-J4-NeuroP 3-((1S,5S)-5-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010484 ent-4-epi-11-J4-NeuroP 3-((1S,5R)-5-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010485 4,11-diepi-11-J4-NeuroP 3-((1R,5S)-5-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010486 ent-11-J4-NeuroP 3-((1R,5R)-5-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010487 11-J4-NeuroP 3-((1S,5S)-5-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010488 ent-4,11-diepi-11-J4-NeuroP 3-((1S,5R)-5-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010489 4-epi-11-J4-NeuroP 3-((1R,5S)-5-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010490 ent-11-epi-11-J4-NeuroP 3-((1R,5R)-5-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010491 13-epi-13-J4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,5S)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010492 ent-16-epi-13-J4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010493 13,16-diepi-13-J4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,5S)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010494 ent-13-J4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010495 13-J4-NeuroP (S,4Z,7Z,10Z,14E)-15-((1S,5S)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010496 ent-13,16-diepi-13-J4-NeuroP (S,4Z,7Z,10Z,14E)-15-((1S,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010497 16-epi-13-J4-NeuroP (S,4Z,7Z,10Z,14E)-15-((1R,5S)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010498 ent-13-epi-13-J4-NeuroP (S,4Z,7Z,10Z,14E)-15-((1R,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010499 14-epi-14-J4-NeuroP (Z)-6-((1S,5S)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010500 ent-7-epi-14-J4-NeuroP (Z)-6-((1S,5R)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010501 7,14-diepi-14-J4-NeuroP (Z)-6-((1R,5S)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410
LMFA04010502 ent-14-J4-NeuroP (Z)-6-((1R,5R)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid FA 22:7;O2 C22H30O4 358.214410